Company / Cash & Equivalents
NATIONAL HEALTH INVESTORS INC Cash & Equivalents History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Cash & Equivalents
$19.6M
FY2025
5-year range
$19.3M / $37.4M
FY2021-FY2025
Trend
-19.2%
vs FY2024
Sector context
#112 of 133
Real Estate
What the data says
NATIONAL HEALTH INVESTORS INC's cash & equivalents of $20M is lower than 84% of companies in the Real Estate sector (FY2025). Cash & Equivalents has fluctuated over the past 10 years, ranging from $3M in FY2017 to $43M in FY2020.
Based on SEC 10-K filings.
$20M in FY2025 with a 5-year CAGR of -14.7%.
Declined from $22M to $20M over the past 2 years.
Real Estate sector context is included.
Cash & Equivalents over time
Growth rates
- 3-Year CAGR
- +0.6%
- 5-Year CAGR
- -14.7%
- 10-Year CAGR
- -
Sector benchmark
Bottom 16% in Real EstateTop 84% of 133This company $19.6M Sector average $334.0M
▼
-94.1% below sector average
Key checks
Key Insights
- 5-year CAGR of -14.7%, indicating a declining trend.
- In FY2025, cash & equivalents decreased 19.2% year-over-year.
- Ranks #112 out of 133 companies in the Real Estate sector.
- Peak cash & equivalents was recorded in FY2020.
Company context
Key Data Points
- Strong profit margin: 41.2%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Cash & EquivalentsValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $19.6M | -19.2% |
| FY2024 | $24.3M | +8.7% |
| FY2023 | $22.3M | +15.8% |
| FY2022 | $19.3M | -48.4% |
| FY2021 | $37.4M | -13.7% |
| FY2020 | $43.3M | +731.1% |
| FY2019 | $5.2M | +11.9% |
| FY2018 | $4.7M | +52.1% |
| FY2017 | $3.1M | -33.9% |
| FY2016 | $4.6M | -64.6% |
As of FY2025 · SEC 10-K · Updated Mar 29, 2026